Schroeder Blake 4
4 · AXIM BIOTECHNOLOGIES, INC. · Filed Mar 19, 2024
Insider Transaction Report
Form 4
Schroeder Blake
Director
Transactions
- Award
Convertible Note
2024-03-15$35000.00/sh+35,000$1,225,000,000→ 4,500,000 totalExercise: $0.01From: 2024-03-15Exp: 2034-03-01→ Common Stock (3,500,000 underlying)
Footnotes (1)
- [F1]Reporting Person acquired a convertible note, face value $35,000. The note is convertible into shares of the Issuer's common stock at a price of $0.01 per share.